Relievant Medsystems
Relievant Medsystems is a medical device company that developed the Intracept Procedure, a minimally invasive treatment that uses radiofrequency ablation of the basivertebral nerve to relieve chronic vertebrogenic low back pain. Originally venture-backed (including by Canaan Partners), Relievant was acquired by Boston Scientific in 2023, and the Intracept system is now marketed under the Boston Scientific portfolio. The company is a clinical medical-device business focused on physicians, hospitals, and patients rather than a software or API platform, and it publishes no public developer API, SDK, or technical integration surface.
Relievant Medsystems is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Medtech, and Pain Management.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API